AUDIOEYE INC (AEYE)

US0507342014 - Common Stock

21.3  -1.05 (-4.7%)

After market: 21.3 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AEYE. AEYE was compared to 282 industry peers in the Software industry. Both the profitability and financial health of AEYE have multiple concerns. AEYE is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year AEYE has reported negative net income.
AEYE had a positive operating cash flow in the past year.
In the past 5 years AEYE always reported negative net income.
In the past 5 years AEYE reported 4 times negative operating cash flow.

1.2 Ratios

AEYE has a Return On Assets of -15.71%. This is in the lower half of the industry: AEYE underperforms 67.50% of its industry peers.
With a Return On Equity value of -71.18%, AEYE is not doing good in the industry: 72.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -15.71%
ROE -71.18%
ROIC N/A
ROA(3y)-38.15%
ROA(5y)-47.93%
ROE(3y)-89.06%
ROE(5y)-172.85%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AEYE's Gross Margin of 78.27% is fine compared to the rest of the industry. AEYE outperforms 76.07% of its industry peers.
In the last couple of years the Gross Margin of AEYE has grown nicely.
The Profit Margin and Operating Margin are not available for AEYE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.14%
GM growth 5Y7.74%

2

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEYE has been increased compared to 1 year ago.
Compared to 5 years ago, AEYE has more shares outstanding
AEYE has a worse debt/assets ratio than last year.

2.2 Solvency

AEYE has an Altman-Z score of 4.51. This indicates that AEYE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AEYE (4.51) is better than 61.79% of its industry peers.
A Debt/Equity ratio of 1.39 is on the high side and indicates that AEYE has dependencies on debt financing.
AEYE's Debt to Equity ratio of 1.39 is on the low side compared to the rest of the industry. AEYE is outperformed by 79.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 4.51
ROIC/WACCN/A
WACC10.34%

2.3 Liquidity

A Current Ratio of 1.16 indicates that AEYE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, AEYE is doing worse than 67.86% of the companies in the same industry.
AEYE has a Quick Ratio of 1.16. This is a normal value and indicates that AEYE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AEYE (1.16) is worse than 67.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.56% over the past year.
The Revenue has been growing slightly by 3.91% in the past year.
Measured over the past years, AEYE shows a very strong growth in Revenue. The Revenue has been growing by 40.80% on average per year.
EPS 1Y (TTM)60.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.71%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y15.21%
Revenue growth 5Y40.8%
Sales Q2Q%8.09%

3.2 Future

The Earnings Per Share is expected to grow by 46.66% on average over the next years. This is a very strong growth
Based on estimates for the next years, AEYE will show a quite strong growth in Revenue. The Revenue will grow by 13.97% on average per year.
EPS Next Y72.42%
EPS Next 2Y46.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.55%
Revenue Next 2Y13.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

AEYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 288.03, AEYE can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AEYE indicates a slightly more expensive valuation: AEYE is more expensive than 63.57% of the companies listed in the same industry.
AEYE is valuated expensively when we compare the Price/Forward Earnings ratio to 23.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 288.03

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AEYE's earnings are expected to grow with 46.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.66%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AEYE!.
Industry RankSector Rank
Dividend Yield N/A

AUDIOEYE INC

NASDAQ:AEYE (10/31/2024, 4:30:00 PM)

After market: 21.3 0 (0%)

21.3

-1.05 (-4.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap253.04M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 288.03
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.71%
ROE -71.18%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 78.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)60.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y72.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.91%
Revenue growth 3Y15.21%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y